Origin Therapeutics Holdings (XCNQ:ORIG) Receivables Turnover : 0.00 (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Origin Therapeutics Holdings's Revenue for the three months ended in Jun. 2023 was C$0.00 Mil. Origin Therapeutics Holdings's average Accounts Receivable for the three months ended in Jun. 2023 was C$0.06 Mil.

Origin Therapeutics Holdings Receivables Turnover Historical Data

The historical data trend for Origin Therapeutics Holdings's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Receivables Turnover Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Receivables Turnover

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Receivables Turnover	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Origin Therapeutics Holdings's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Origin Therapeutics Holdings's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Origin Therapeutics Holdings's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Origin Therapeutics Holdings's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Origin Therapeutics Holdings's Receivables Turnover falls into.

Origin Therapeutics Holdings Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Origin Therapeutics Holdings's Receivables Turnover for the fiscal year that ended in Sep. 2022 is calculated as

	Receivables Turnover (A: Sep. 2022 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Sep. 2022 )	/ (	(Accounts Receivable (A: Sep. 2021 )	+	Accounts Receivable (A: Sep. 2022 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Origin Therapeutics Holdings's Receivables Turnover for the quarter that ended in Jun. 2023 is calculated as

	Receivables Turnover (Q: Jun. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Jun. 2023 )	/ (	(Accounts Receivable (Q: Mar. 2023 )	+	Accounts Receivable (Q: Jun. 2023 ))	/	count )
=	0	/ (	(0.043	+	0.071)	/	2 )
=	0	/	0.057
=	N/A

Origin Therapeutics Holdings (XCNQ:ORIG) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Origin Therapeutics Holdings Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.